Abiopharma

Clinical trial NCT06492707: enrollment: 20 → 40 participants.

Clinical trial NCT05999968: status: COMPLETED → TERMINATED.

Clinical trial NCT06800313 updates: 1. start date: 2025-02-24 → 2025-02-20 2. completion date: 2027-03-01 → 2030-04-01 3. primary completion date: 2027-03-01 → 2028-04-01 4. enrollment: 33 → 190 participants 5. allocation: NA → NON_RANDOMIZED

Clinical trial NCT06640023 updates: 1. status: ENROLLING_BY_INVITATION → ACTIVE_NOT_RECRUITING 2. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT04488822: completion date: 2026-02-28 → 2027-03-31.

Clinical trial NCT07663994: status: NOT_YET_RECRUITING → RECRUITING.

Clinical trial NCT07597018 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. completion date: 2027-05-28 → 2027-06-01

Clinical trial NCT07198087 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-12-31 → 2026-04-20

Clinical trial NCT03981640 updates: 1. completion date: 2026-04-01 → 2026-08-01 2. primary completion date: 2026-04-01 → 2026-08-01

Clinical trial NCT04645589 updates: 1. completion date: 2025-06-13 → 2025-08-13 2. primary completion date: 2025-06-13 → 2025-08-13 3. enrollment: 72 → 69 participants